Dermata Therapeutics Inc. (NASDAQ: DRMA)
$2.12
-0.0700 ( -3.20% ) 71.5K
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
Market Data
Open
$2.12
Previous close
$2.19
Volume
71.5K
Market cap
$1.39M
Day range
$1.90 - $2.24
52 week range
$1.90 - $24.60
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 19 | Jun 07, 2024 |
8-k | 8K-related | 15 | Jun 05, 2024 |
8-k | 8K-related | 15 | May 24, 2024 |
8-k | 8K-related | 19 | May 17, 2024 |
8-k | 8K-related | 15 | May 15, 2024 |
10-q | Quarterly Reports | 47 | May 15, 2024 |
8-k | 8K-related | 17 | May 15, 2024 |
8-k | 8K-related | 16 | May 14, 2024 |
8-k | 8K-related | 16 | May 07, 2024 |
def | Proxies and info statements | 6 | Mar 26, 2024 |